78 related articles for article (PubMed ID: 20950213)
21. A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.
Korhonen K; Auvinen A; Lyytinen H; Ylikorkala O; Pukkala E
Am J Epidemiol; 2012 Feb; 175(4):309-14. PubMed ID: 22287638
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer: the role of hormone therapy.
Creasman WT
Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202
[TBL] [Abstract][Full Text] [Related]
23. Hormone therapy and breast cancer risk.
Foidart JM; Desreux J; Pintiaux A; Gompel A
Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
[TBL] [Abstract][Full Text] [Related]
24. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
McGonigle KF; Karlan BY; Barbuto DA; Leuchter RS; Lagasse LD; Judd HL
Gynecol Oncol; 1994 Oct; 55(1):126-32. PubMed ID: 7959253
[TBL] [Abstract][Full Text] [Related]
25. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
26. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
[TBL] [Abstract][Full Text] [Related]
27. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
[TBL] [Abstract][Full Text] [Related]
28. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
29. Estrogen replacement therapy in the elderly.
Paganini-Hill A
Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
[TBL] [Abstract][Full Text] [Related]
30. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
[TBL] [Abstract][Full Text] [Related]
31. Hormone replacement therapy in women with breast cancer.
Braendle W
Anticancer Res; 1998; 18(3C):2253-5. PubMed ID: 9703796
[TBL] [Abstract][Full Text] [Related]
32. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
van de Weijer PH; Mattsson LA; Ylikorkala O
Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
[TBL] [Abstract][Full Text] [Related]
33. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
[TBL] [Abstract][Full Text] [Related]
34. Hormone therapy and brain tumors.
Pines A
Climacteric; 2011 Apr; 14(2):215-6. PubMed ID: 21067422
[TBL] [Abstract][Full Text] [Related]
35. Hormone therapy and young-onset breast cancer.
O'Brien KM; Fei C; Sandler DP; Nichols HB; DeRoo LA; Weinberg CR
Am J Epidemiol; 2015 May; 181(10):799-807. PubMed ID: 25698646
[TBL] [Abstract][Full Text] [Related]
36. Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study.
Clague J; Reynolds P; Henderson KD; Sullivan-Halley J; Ma H; Lacey JV; Chang S; Delclos GL; Du XL; Forman MR; Bernstein L
PLoS One; 2014; 9(7):e103735. PubMed ID: 25079077
[TBL] [Abstract][Full Text] [Related]
37. Postmenopausal hormone therapy in the aftermath of the WHI. What patients need to know.
Cyr MG
Postgrad Med; 2003 Mar; 113(3):15-8, 20. PubMed ID: 12647471
[TBL] [Abstract][Full Text] [Related]
38. The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study.
Wu CC; Chung CH; Tzeng NS; Wu MJ; Tsao CH; Wu TH; Chien WC; Chen HC
Menopause; 2023 May; 30(5):521-528. PubMed ID: 36854166
[TBL] [Abstract][Full Text] [Related]
39. Hormone therapy and lung cancer mortality in women: Systematic review and meta-analysis.
Li W; Lin X; Wang R; Wang F; Xie S; Tse LA
Steroids; 2017 Feb; 118():47-54. PubMed ID: 27964943
[TBL] [Abstract][Full Text] [Related]
40. Lung cancer and hormone replacement therapy.
Grant EC
Lancet; 2010 Jan; 375(9709):117; author reply 118-9. PubMed ID: 20109880
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
